Translational cancer research is a multidisciplinary approach that aims to transform basic scientific discoveries into effective clinical applications for cancer prevention, diagnosis, and treatment. It bridges the gap between laboratory research and patient care by integrating molecular biology, genomics, pharmacology, and clinical oncology. Findings from basic research, such as identification of genetic mutations, signaling pathways, and molecular targets involved in cancer, are translated into the development of new diagnostic tools, biomarkers, and targeted therapies. This approach helps in understanding disease mechanisms at a deeper level and applying that knowledge to improve patient outcomes.
| 2-5 Days | Initial Quality & Plagiarism Check |
| 15 Days |
Peer Review Feedback |
| 85% | Acceptance Rate (after peer review) |
| 30-45 Days | Total article processing time |